Skip to Main Content

Paper Details

NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
Cancer Immunol Res
25
2022
CD8, CD8 T, CD8 T cells, CD8 T-cell, CTL, Cancer, Cytotoxic CD8 T cells, ETS1, NKG7, PD-1, PD-L1, T, T cells, T-cell, anti-PD-1, calcium, cancer, human, human CD8 T cells, human CTLs, human T cells, mRNA, malignant, murine, murine tumor antigen-specific CD8 T cells, natural killer cell granule protein-7, patients, peripheral CD8 T cells, rapidly proliferating malignant cells, tumor
Author NameAffiliation
Fabrice LucienMayo Clinic
Hu LiCenter for Individualized Medicine, Mayo Clinic College of Medicine and Science
Cristina CorreiaCenter for Individualized Medicine, Mayo Clinic College of Medicine and Science
Minetta C LiuMayo Clinic
Daniel D BilladeauMayo Clinic College of Medicine and Science
  • 1 - 5

Datasets

Release 1.2